Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma.
Hiroaki MatsumotoKaoru TsuchiyaHiroyuki NakanishiYuka HayakawaYutaka YasuiNaoki UchiharaKeito SuzukiYuki TanakaHaruka MiyamotoShun IshidoMichiko YamadaTaisei KeitokuTsubasa NobusawaMayu HiguchiKenta TakauraShohei TanakaChiaki MaeyashikiNobuharu TamakiYuka TakahashiMasayuki KurosakiYasuhiro AsahinaRyuichi OkamotoNamiki IzumiPublished in: Cancers (2022)
Decreased SMI was significantly associated with PFS. Monitoring muscle volume during atezolizumab plus bevacizumab therapy is useful in clinical practice.